Cargando…

Why does milnacipran produce so few discontinuation syndromes following abrupt withdrawal?

Detalles Bibliográficos
Autor principal:	Okada, Fumihiko
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654522/ https://www.ncbi.nlm.nih.gov/pubmed/19300550

Ejemplares similares

Hypomania following Abrupt Lithium withdrawal
por: Gupta, Rajeev
Publicado: (1987)

Why are there so few (or so many) circulating coronaviruses?
por: Rice, Benjamin L., et al.
Publicado: (2021)

Laws of biology: why so few?
por: Dhar, Pawan K., et al.
Publicado: (2009)

Why does Japan have so few cases of COVID‐19?
por: Iwasaki, Akiko, et al.
Publicado: (2020)

Acute Abdomen in a Child following Abrupt Withdrawal of Imipramine - A Case Report
por: Gupta, Rajeev
Publicado: (1989)

Effect of high-dose milnacipran in patients with depression
por: Hayashi, Masatoshi, et al.
Publicado: (2007)

Transient Splenial Lesion Following Abrupt Withdrawal of Carbamazepine
por: Fuseya, Yasuhiro, et al.
Publicado: (2017)

The arrival of Mpox in Venezuela: Why so few cases?
por: Comegna, Mario, et al.
Publicado: (2023)

Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine
por: Gahr, Maximilian, et al.
Publicado: (2020)

Factors Associated With Abrupt Discontinuation of Long-Term High-Dose Opioid Treatment
por: Vivas-Valencia, Carolina, et al.
Publicado: (2023)

Milnacipran for the management of fibromyalgia syndrome
por: Ormseth, Michelle J, et al.
Publicado: (2010)

Why Do Heterosporous Plants Have So Few Chromosomes?
por: Kinosian, Sylvia P., et al.
Publicado: (2022)

Why Are There So Few FDA-Approved Therapeutics for Wound Healing?
por: Chen, Mei, et al.
Publicado: (2023)

Excessive sweating in a male patient caused by milnacipran
por: Shinohara, Yutaka
Publicado: (2009)

Use of milnacipran in patients suffering from poststroke depression
por: Arora, Harish, et al.
Publicado: (2009)

Unraveling Complexity in the Solid Form Screening of a Pharmaceutical Salt: Why so Many Forms? Why so Few?
por: Braun, Doris E., et al.
Publicado: (2017)

Acute-Withdrawal Restless Legs Syndrome Following Abrupt Cessation of Short-Term Tramadol
por: Park, Young-Min, et al.
Publicado: (2014)

Improvement of the noradrenergic symptom cluster following treatment with milnacipran
por: Kasper, Siegfried, et al.
Publicado: (2011)

Catatonia induced by abrupt discontinuation of clozapine - case report
por: Oliveira, C., et al.
Publicado: (2021)

Milnacipran: recent findings in depression
por: Montgomery, Stuart, et al.
Publicado: (2010)

Antidepressant therapy with milnacipran and venlafaxine
por: Mansuy, Lucilla
Publicado: (2010)

Milnacipran: a unique antidepressant?
por: Kasper, Siegfried, et al.
Publicado: (2010)

Why So Salty? Transient Diabetes Insipidus After Discontinuation of Vasopressin
por: Urban, Jacqueline A., et al.
Publicado: (2022)

Why Do so Few People with Heart Failure Receive Cardiac Rehabilitation?
por: Thompson, David R, et al.
Publicado: (2022)

So Many Are “Few,” but so Few Are Also “Few” – Reduced Semantic Flexibility in bvFTD Patients
por: Heim, Stefan, et al.
Publicado: (2020)

If so many are “few,” how few are “many”?
por: Heim, Stefan, et al.
Publicado: (2015)

Pruritus associated with abrupt mirtazapine discontinuation: Single case report
por: Spitznogle, Brittany, et al.
Publicado: (2019)

Why Are There So Few Rickettsia conorii conorii-Infected Rhipicephalus sanguineus Ticks in the Wild?
por: Socolovschi, Cristina, et al.
Publicado: (2012)

Why Do So Few HMOs Offer Medicare Risk Plans in Rural Areas?
por: Serrate, Carl, et al.
Publicado: (1995)

Why is medical education so expensive?
por: Walsh, Kieran
Publicado: (2014)

Abrupt withdrawal of inhaled corticosteroids does not result in spirometric deterioration in chronic obstructive pulmonary disease: Effect of phenotyping?
por: Al-Kassimi, Feisal A., et al.
Publicado: (2012)

Withdrawal Symptoms Following Discontinuation of Vortioxetine—Retrospective Chart Review
por: Siwek, Marcin, et al.
Publicado: (2021)

Why so Few, Still? Challenges to Attracting, Advancing, and Keeping Women Faculty of Color in Academia
por: Fox Tree, Jean E., et al.
Publicado: (2022)

Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
por: Yoshimura, Reiji, et al.
Publicado: (2022)

Role and rationale for the use of milnacipran in the management of fibromyalgia
por: Kranzler, Jay D, et al.
Publicado: (2010)

Evaluation of the Neurological Safety of Epidural Milnacipran in Rats
por: Lim, Seung Mo, et al.
Publicado: (2012)

Effect of milnacipran on body weight in patients with fibromyalgia
por: Arnold, Lesley M, et al.
Publicado: (2012)

Usefulness of milnacipran in treating phantom limb pain
por: Nagoshi, Yasuhide, et al.
Publicado: (2012)

Toxic Encephalopathy After Relapsed Indolent Non-Hodgkin’s Lymphoma Following Abrupt Discontinuation of Idelalisib (ZYDELIG®)
por: Shenouda, Mina, et al.
Publicado: (2019)

Treatment of phantom bite syndrome with milnacipran – a case series
por: Toyofuku, Akira, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_c7sst7v3samdb1rn81ulj6rf0l